Document is current
Any future updates will be listed below
-
Authors
Stanslaski, Scott https://orcid.org/0000-0002-3513-2391
Summers, Rebekah L. S.
Tonder, Lisa
Tan, Ye
Case, Michelle
Raike, Robert S.
Morelli, Nathan
Herrington, Todd M.
Beudel, Martijn https://orcid.org/0000-0002-2488-7051
Ostrem, Jill L.
Little, Simon https://orcid.org/0000-0001-6249-6230
Almeida, Leonardo
Ramirez-Zamora, Adolfo https://orcid.org/0000-0001-9253-3899
Fasano, Alfonso https://orcid.org/0000-0001-5346-0180
Hassell, Travis
Mitchell, Kyle T.
Moro, Elena
Gostkowski, Michal
Sarangmat, Nagaraja
Bronte-Stewart, Helen https://orcid.org/0000-0002-1839-4541
,
- License Information
-
More Information
Article History
Received: 2 December 2023
Accepted: 5 August 2024
First Online: 17 September 2024
Competing interests
: This study is funded by Medtronic and employees of Medtronic have been involved in the conceptualization, design, data collection and analysis, and preparation of the manuscript as it is a pivotal trial of adaptive deep brain stimulation. S.S., R.S., L.T., Y.T., R.R., M.C., and N.M. are employees of Medtronic and may hold shares and/or stock options in the company. All investigators and their institutions received sponsorship for the conduct of the ADAPT-PD clinical trial from Medtronic. J.O. reports research support from Medtronic and Boston Scientific, and consulting payments from Abbott. L.A. has received honoraria from educational and advisory board consulting work for Medtronic and Boston Scientific. K.M. reports research support from Medtronic, Boston Scientific, and Surgical Information Sciences and consulting payments from Medtronic and Boston Scientific. T.H. reports research support from Medtronic and Boston Scientific and consulting payments from Medtronic. E.M. reports research support from Abbott and consulting payments from Abbott and Medtronic. E.M. is Associate Editor of <i>npj Parkinson’s Disease</i>. E.M. was not involved in the journal’s review of, or decisions related to, this manuscript. M.G. reports research support from Medtronic. A.R.Z. reports consulting for Medtronic. A.F. reports research support from Abbvie, Boston Scientific, Medtronic and consults for Abbvie, Abbott, Boston Scientific, Inbrain, Ipsen, Medtronic, Sunovion, Syneos Health and sits on advisory boards for Abbvie, Medtronic, Boston Scientific, Ceregate, Inbrain, Ipsen. A.F. also receives honoraria from Abbvie, Abbott, American Academy of Neurology, Boston Scientific, Brainlab, Ipsen, Medtronic, Merz, Movement Disorders Society, Sunovion, Paladin Labs, UCB. A.F. receives royalties from Springer. S.L. reports consulting for Iota Biosciences. N.S. has nothing to disclose. S.S. holds relevant patents to adaptive deep brain stimulation.
